Long Focus Capital Management, LLC Abb Vie Inc. Call Options Transaction History

Long Focus Capital Management, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $688,100 - $874,800	-5,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $2.64 Million - $3.28 Million	-20,000 Reduced 80.0%	5,000 $811,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $2.69 Million - $3.4 Million	25,000 New	25,000 $3.39 Million

3,848

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Long Focus Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Long Focus Capital Management, LLC with notifications on news.